Colin Dormuth
Biographic Data
| ID | 5538773 |
|---|---|
| NAME | Colin Dormuth |
| GIVEN NAMES | Colin |
| FAMILY NAME | Dormuth |
| SIGNATURE | DORMUTH C |
| VERIFIED | No |
| TOTAL WORKS | 2 |
| TOTAL CITATIONS | 0 |
| WORKS AS AUTHOR | 2 |
| WORKS AS EDITOR | 0 |
| FIRST PUBLICATION YEAR | 2004 |
| LATEST PUBLICATION YEAR | 2007 |
| H-INDEX | 0 |
Evaluating the Validity of an Instrumental Variable Study of Neuroleptics
BACKGROUND: Postmarketing studies of prescription drugs are challenging because prognostic variables that determine treatment choices are often unmeasured. In this setting, instrumental variable (IV) methods that exploit differences in prescribing patterns between physicians may be used to estimate treatment effects; however, IV methods require strong assumptions to yield consistent estimates. We sought to explore the validity of physician-level …
Net Health Plan Savings From Reference Pricing for Angiotensin-Converting Enzyme Inhibitors in Elderly British Columbia Residents
BACKGROUND: Reference drug pricing (RP) is a cost-sharing strategy commonly used to control drug expenditures. Under RP, a benefit plan fully reimburses medications that are equally or less expensive than the reference price, and requires patients to pay the extra cost of therapeutically equivalent but higher priced drugs. Critics argued that drug plan savings are offset by administrative costs and increased spending on other health services. OBJ…
No prominent works on this page.
Net Health Plan Savings From Reference Pricing for Angiotensin-Converting Enzyme Inhibitors in Elderly British Columbia Residents
BACKGROUND: Reference drug pricing (RP) is a cost-sharing strategy commonly used to control drug expenditures. Under RP, a benefit plan fully reimburses medications that are equally or less expensive than the reference price, and requires patients to pay the extra cost of therapeutically equivalent but higher priced drugs. Critics argued that drug plan savings are offset by administrative costs and increased spending on other health services. OBJ…
Evaluating the Validity of an Instrumental Variable Study of Neuroleptics
BACKGROUND: Postmarketing studies of prescription drugs are challenging because prognostic variables that determine treatment choices are often unmeasured. In this setting, instrumental variable (IV) methods that exploit differences in prescribing patterns between physicians may be used to estimate treatment effects; however, IV methods require strong assumptions to yield consistent estimates. We sought to explore the validity of physician-level …
Health Systems, Economic Evaluations, Quality of Life (2 works) · Actuarial science (1 work) · Advanced Causal Inference Techniques (1 work) · Business (1 work) · Cohort (1 work) · Cohort study (1 work) · Confidence interval (1 work) · Defined daily dose (1 work) · Economic growth (1 work) · Economics (1 work)